1) Malbica, J., Sello, L., Tabenkin, B., Berger, J., Grunberg, E., Burchenal, J. H., Fox, J. J., Wempen, I., Gabriel, T. and Duschinsky, R.: Some biological properties of 5-fluorocytosine and its derivatives. Federation Proc., 21: 384, 1962.
2) Grunberg, E. E., Tisworth, E. and Bennett, M.: Chemotherapeutic activity of 5-fluorocytosine. Antimicrob. Agents & Chemother. 1963, p. 566-568, 1964.
3) Grunberg, E, E., Prince, H. N. and Utz, J. P.: Observations on the activity of two newer antifungal agents, saramycetin (X-5079C) and 5-fluorocytosine. In: 5th International Congress of Chemotherapy (Vienna, Austria, 26 June-1 July, 1967), Vol. 4, p. 69-76, Med. Akademie, Vienna, 1967.
4) Tassel, D. and Madoff, M. A.: Treatment of Candida sepsis and Cryptococcus meningitis with 5-fluorocytosine. J. A. M. A., 206: 830-832, 1968.
5) Fass, R. J. and Perkins, R. L.: 5-Fluorocytosine in the treatment of cryptococcal and candida mycoses. Ann. Intern. Med., 74: 535-539, 1971.